PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Profitability reveals how effectively the business turns revenues into profits. Higher and improving margins or returns on capital suggest a durable competitive advantage, supporting a stronger intrinsic valuation.
-2.32%
Both companies show negative ROE. Martin Whitman would check if the entire market segment is distressed.
-1.00%
Both firms have negative ROA. Martin Whitman would investigate if the market environment is extremely challenging.
-0.92%
Negative ROCE while VET is at 1.86%. Joel Greenblatt would look for capital misallocation or cyclical downturn.
40.69%
Gross margin 50-75% of VET's 56.51%. Martin Whitman would worry about a persistent competitive disadvantage.
-11.80%
Negative operating margin while VET has 24.48%. Joel Greenblatt would demand urgent improvements in cost or revenue.
-15.36%
Both companies run at a net loss. Martin Whitman would see if broader market headwinds persist.